Clinical Trial Update: Oxycodone/Naloxone (OXN) Combination in Moderate to Severe Non-malignant Pain [Phase 3]

View source ↗

Summary

Phase 3 trial update of oxycodone/naloxone for moderate to severe non-malignant (noncancer) pain, completed by Mundipharma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Noncancer Pain

Drugs mentioned

• Oxycodone/naloxone (OXN) (oxycodone/naloxone)

Snippet

Sponsor: Mundipharma Pharmaceuticals B.V. | Conditions: Pain | Phase 3 | Status: COMPLETED